Skip to content

REPURPOSING POVIDONE IODINE FOR THE TREATMENT OF CHRONIC SUPPURATIVE OTITIS MEDIA AMONG CHILDREN IN NIGERIA

REPURPOSING POVIDONE IODINE FOR THE TREATMENT OF CHRONIC SUPPURATIVE OTITIS MEDIA AMONG CHILDREN IN NIGERIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202205661725946
Enrollment
390
Registered
2022-05-09
Start date
2022-05-09
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear, Nose and Throat

Interventions

Povidone iodine and oral amoxicillin clavulanic acid
Ciprofloxacin eardrop and Oral amoxicillin clavulanic acid

Sponsors

University College Hospital Ibadan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children aged between 6months and 14years with uncomplicated CSOM Children with otorrhea and central tympanic membrane perforation, which has lasted for at least 6weeks duration Children with above condition whose parents/caregiver give consent

Exclusion criteria

Exclusion criteria: 1) Children whose parents/guardian refuse consent 2) Children allergic to iodine, ciprofloxacin and penicillin 3) Children with complicated CSOM 4) Children with marginal tympanic membrane perforation 5) Children with underlying immunodeficiency 6) Children with other chronic medical conditions

Design outcomes

Primary

MeasureTime frame
The primary outcome of the proposed research is resolution of otorrhea

Secondary

MeasureTime frame
Reduction in the diameter of tympanic membrane perforation, improved auditory threshold and the eradication of pathologic microbes from the middle ear.

Countries

Nigeria

Contacts

Public ContactAyotunde James Fasunla

Associate Professor of Otorhinolaryngology University of Ibadan

ayofasunla@gmail.com+2348033740220

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026